Peking University Cancer Hospital, Doctor of Medicine, Chief Physician, Master's Supervisor. Senior Visiting Scholar at the University of Pittsburgh Medical Center, USA, in 2010. Expertise: Primarily engaged in clinical and translational research on melanoma and urological tumors; main research focus is on clinical and translational studies of melanoma and urological system tumors. Previously systematically elucidated the classification and prognosis of melanoma patients in China. As a key contributor, established the TNM staging system for mucosal melanoma, facilitating comprehensive assessment, treatment analysis, and design of prospective studies for mucosal melanoma from different primary sites. As a principal investigator, participated in a series of clinical studies on perioperative and advanced treatment of most mucosal melanoma cases in China, revising domestic melanoma guidelines. In the past five years, as corresponding author, first author, or co-first author, published 13 SCI articles in internationally renowned oncology journals such as Annals of Oncology, NPJ Genomic Medicine, and European Journal of Cancer, with the highest impact factor of 50.5. Part-time Positions: Council Member of the Chinese Society of Clinical Oncology (CSCO) Standing Committee Member of the CSCO Melanoma Professional Committee Secretary of the CSCO Urothelial Carcinoma Professional Committee Youth Committee Member of the Beijing Anti-Cancer Association's Genitourinary Oncology Professional Committee As a major participant, received the Second Prize of the Beijing Science and Technology Progress Award, the Second Prize of the China Anti-Cancer Association Science and Technology Progress Award, the Third Prize of the Chinese Medical Association Science and Technology Award, and the Third Prize of the Huaxia Medical Award.